|
My dream is, in addition to bringing it to humans, to have at least one larval biotherapy unit in each state of Brazil, that someone will also be delighted with and do it, because it will be very useful for those who need it, both animals and humans”, shares Silvia. This researcher's idea is justified by the fact that Lapavet is unable to supply larvae to distant regions of the country, as, depending on the travel time, the larvae run the risk of dying. Furthermore, there is no suitable material or form of travel that supports the journey for the animal. That's why the laboratory focuses on handling cases in the state. “As for São Paulo, if there is logistics that allows the larvae to arrive within 48 hours, we send them. We can maintain it at a certain temperature to prevent their development or f information and the positive results arising from biotherapy. Janaína agrees and adds that the main point now is to disassociate the image that comes to mind when talking about the subject, when publicizing clinical cases, as well as teaching larval therapy courses, their benefits and applications, to facilitate access to knowledge of the technique by the general population and health professionals.
Believe that work like ours reaches professionals from different areas and encourages the use of biotherapy, as it is a cheap, safe and effective technique against resistant bacteria in wound beds”, says Janaína. Time for the researchers to meet with the reference in the area Along these lines, Silvia also shares concerns about the insecurity of health professionals in applying the treatment. The teacher reinforces the intention to promote teaching so that they can lose their fear when requested by patients. Silvia says that the ideal scenario is what occurs in countries like the United States, England DM Databases and Australia. There, she observes how treatments are more common, people are treated in hospitals or receive the application at home by a professional. Most cases involve people with diabetes, who have more difficulty with healing. Recognition by the father of biotherapy The work carried out at UFSM has already begun to be known around the world. With the publication of an article on Janaína's thesis in the journal Experimental Parasitology, Ronald Sherman, considered the father of biotherapy, invited the study's advisor and advisor to a live broadcast , on March.
The live was on the channel of the institution to which Sherman is linked, the BioTherapeutics, Education & Research (BTER) Foundation , a non-profit organization dedicated to the advancement of healthcare, specializing in public support and professional education in biotherapeutic medicine. “He is very well known, everything that has been done on biotherapy has his name or is referenced”, adds the professor, who despite not being fluent in English agreed to participate, as it was an opportunity to publicize what is being done. "It was a success. We opened a door and have already sent work to each other,” she says. Text: Gabrielle Pillon, Journalism academic and fellow at the Agência de Notícias Photos: Ana Alícia Flores, Industrial Design academic and fellow at the Agência de Notícias Edition: Ricardo Bonfanti, journalistLast Thursday (27), the Oswaldo Cruz Foundation (Fiocruz), linked to the Ministry of Health, held an online award ceremony for the 10 most important collaborators of the Citizen Science Platform Wild Health Information System-SISS- Geo , a cell phone application in which occurrences of living, sick or dead wild animals are recorded.
|
|